Opinion of Polish Patients with Epilepsy on Generic Medications

Author:

Swakowska Katarzyna1,Religioni Urszula2ORCID,Staniszewska Anna3ORCID

Affiliation:

1. Civitas 24 GmbH, 55122 Mainz, Germany

2. School of Public Health, Centre of Postgraduate Medical Education of Warsaw, 01-826 Warsaw, Poland

3. Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, 02-097 Warsaw, Poland

Abstract

Aim: The majority of medicines used in Poland are generic drugs and substitutions of the originals. The objective of this study was to obtain information on the current knowledge about generic medicines among Polish patients with epilepsy. Material and Methods: The conducted study was based on a self-developed questionnaire. The questionnaire consisted of 26 questions, including the questions regarding the respondents’ knowledge about generics, their previous experience, and the factors behind these choices. Results: Overall, 1220 questionnaires were analyzed. Among all patients, 66.4% reportedly had heard about generics. Of these, 61.5% of patients had used generic drugs in the past. A significant proportion of participants had never been recommended to switch to a generic medicine by their healthcare professional (23% physicians and 13.9% pharmacists). Statistically, relevant differences were observed regarding the respondents’ kind and level of education, place of residence, and net income per household. Conclusions: Significant gaps were identified in the knowledge and perceptions among patients regarding generic medicines, especially in relation to their efficacy and safety. Efforts must be directed towards increasing public awareness of generic medicines and there should also be a focus on educating patients about generic medicines.

Publisher

MDPI AG

Subject

Health Information Management,Health Informatics,Health Policy,Leadership and Management

Reference41 articles.

1. The impact of generic medicines on the European pharmaceutical market: The example of Poland;Matsuieva;Ekon.—Wroc. Econ. Rev.,2017

2. Malaysian generic pharmaceutical industries: Perspective from healthcare stakeholders;Wong;J. Pharm. Health Serv. Res.,2014

3. Iran pharmaceutical market;Cheraghali;Iran. J. Pharm. Res.,2017

4. Wydatki na ochronę zdrowia w gospodarstwach domowych [Health care expenditures in households];Piekut;Pol. Przegląd Nauk. Zdrowiu,2016

5. Health care expenditure of households in magway, myanmar;Khaing;Nagoya J. Med. Sci.,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3